| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.52B | $2.27B | $1.97B |
| YoY Revenue Growth % | +11.0% | +15.3% | — |
| Gross Profit | $1.05B | $936.9M | — |
| Gross Margin % | 41.6% | 41.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $80.8M | $224.9M | $213.2M |
| Operating Margin % | 3.2% | 9.9% | 10.8% |
| Net Income (GAAP) | $44.7M | $169.4M | $171.6M |
| EBITDA (Normalized) | $114.9M | $245.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $162.2M | $198.1M | $229.2M |
| Capital Expenditures (CapEx) | $42.7M | $25.9M | — |
| Free Cash Flow (FCF) | $119.5M | $172.2M | $229.2M |
| FCF Margin % | 4.7% | 7.6% | 11.6% |
| Return on Invested Capital (ROIC %) | 6.5% | 27.0% | — |
| Cash & Short-Term Equivalents | $112.4M | $189.9M | — |
| Total Debt (Short + Long Term) | $234.2M | $0 | — |
| Total Stockholders' Equity | $866.4M | $847.7M | — |